Extract
AMPLIPHI BIOSCIENCES Announces First Closing of $2.7m.
RICHMOND, Va. & SEATTLE, Wa. & COLWORTH, UK -- AmpliPhi Biosciences Corporation (APHB.PK), the leader in the development of bacteriophage-based anti-bacterial therapies to treat drug resistant infections, has announced that is has closed on an initial amount of $...
See the full content of this document
Sponsored links
